Dr. Tait D Shanafelt
Claim this profileStudies T-Lymphoblastic Leukemia/Lymphoma
Studies Lymphoid Leukemia
1 reported clinical trial
3 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
CD3 negative
CD23 positive
CD5 positive
2Lymphoid Leukemia
CD3 negative
CD23 positive
CD5 positive
More about Tait D Shanafelt
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Tait D Shanafelt has experience with
- Ibrutinib
- Obinutuzumab
- Venetoclax
Breakdown of trials Tait D Shanafelt has run
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tait D Shanafelt specialize in?
Tait D Shanafelt focuses on T-Lymphoblastic Leukemia/Lymphoma and Lymphoid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved CD3 negative patients, or patients who are CD23 positive.
Is Tait D Shanafelt currently recruiting for clinical trials?
No, Tait D Shanafelt is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Tait D Shanafelt has studied deeply?
Yes, Tait D Shanafelt has studied treatments such as Ibrutinib, Obinutuzumab, Venetoclax.
What is the best way to schedule an appointment with Tait D Shanafelt?
Apply for one of the trials that Tait D Shanafelt is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.